Grey matter damage in multiple sclerosis

References

• Lublin FD, Reingold SC, National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46:907 - 11; http://dx.doi.org/10.1212/WNL.46.4.907; PMID: 8780061
   PubMed Web of Science ®Google Scholar
• Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol 2006; 5:343 - 54; http://dx.doi.org/10.1016/S1474-4422(06)70410-0; PMID: 16545751
   PubMed Web of Science ®Google Scholar
• Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007; 6:903 - 12; http://dx.doi.org/10.1016/S1474-4422(07)70243-0; PMID: 17884680
   PubMed Web of Science ®Google Scholar
• Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999; 122:625 - 39; http://dx.doi.org/10.1093/brain/122.4.625; PMID: 10219776
   PubMed Web of Science ®Google Scholar
• Bö L, Geurts JJG, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007; 64:76 - 80; http://dx.doi.org/10.1001/archneur.64.1.76; PMID: 17210812
   PubMed Web of Science ®Google Scholar
• Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962; 25:315 - 20; http://dx.doi.org/10.1136/jnnp.25.4.315; PMID: 14016083
   PubMed Web of Science ®Google Scholar
• Bø L, Vedeler CA, Nyland HI, Trapp BD, Mørk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62:723 - 32; PMID: 12901699
   PubMed Web of Science ®Google Scholar
• Bø L, Vedeler CA, Nyland H, Trapp BD, Mørk SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003; 9:323 - 31; http://dx.doi.org/10.1191/1352458503ms917oa; PMID: 12926836
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128:2705 - 12; http://dx.doi.org/10.1093/brain/awh641; PMID: 16230320
   PubMed Web of Science ®Google Scholar
• Dutta R, Chang A, Doud MK, Kidd GJ, Ribaudo MV, Young EA, et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol 2011; 69:445 - 54; http://dx.doi.org/10.1002/ana.22337; PMID: 21446020
   PubMed Web of Science ®Google Scholar
• Geurts JJG, Bö L, Roosendaal SD, Hazes T, Daniëls R, Barkhof F, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007; 66:819 - 27; http://dx.doi.org/10.1097/nen.0b013e3181461f54; PMID: 17805012
   PubMed Web of Science ®Google Scholar
• Gilmore CP, Bö L, Owens T, Lowe J, Esiri MM, Evangelou N. Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol 2006; 16:202 - 8; http://dx.doi.org/10.1111/j.1750-3639.2006.00018.x; PMID: 16911477
   PubMed Web of Science ®Google Scholar
• Gilmore CP, Donaldson I, Bö L, Owens T, Lowe J, Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009; 80:182 - 7; http://dx.doi.org/10.1136/jnnp.2008.148767; PMID: 18829630
   PubMed Web of Science ®Google Scholar
• Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 2001; 60:1208 - 18; PMID: 11764093
   PubMed Web of Science ®Google Scholar
• Kooi E-J, Prins M, Bajic N, Beliën JAM, Gerritsen WH, van Horssen J, et al. Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathol 2011; 122:313 - 22; http://dx.doi.org/10.1007/s00401-011-0849-4; PMID: 21691765
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007; 17:38 - 44; http://dx.doi.org/10.1111/j.1750-3639.2006.00041.x; PMID: 17493036
   PubMed Web of Science ®Google Scholar
• Papadopoulos D, Dukes S, Patel R, Nicholas R, Vora A, Reynolds R. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 2009; 19:238 - 53; http://dx.doi.org/10.1111/j.1750-3639.2008.00177.x; PMID: 18492094
   PubMed Web of Science ®Google Scholar
• Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50:389 - 400; http://dx.doi.org/10.1002/ana.1123; PMID: 11558796
   PubMed Web of Science ®Google Scholar
• Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64:1101 - 7; http://dx.doi.org/10.1097/01.jnen.0000190067.20935.42; PMID: 16319720
   PubMed Web of Science ®Google Scholar
• Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006; 67:960 - 7; http://dx.doi.org/10.1212/01.wnl.0000237551.26858.39; PMID: 17000961
   PubMed Web of Science ®Google Scholar
• Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009; 68:489 - 502; http://dx.doi.org/10.1097/NEN.0b013e3181a19a5a; PMID: 19525897
   PubMed Web of Science ®Google Scholar
• Squire LR, Stark CEL, Clark RE. The medial temporal lobe. Annu Rev Neurosci 2004; 27:279 - 306; http://dx.doi.org/10.1146/annurev.neuro.27.070203.144130; PMID: 15217334
   PubMed Web of Science ®Google Scholar
• Moscovitch M, Nadel L, Winocur G, Gilboa A, Rosenbaum RS. The cognitive neuroscience of remote episodic, semantic and spatial memory. Curr Opin Neurobiol 2006; 16:179 - 90; http://dx.doi.org/10.1016/j.conb.2006.03.013; PMID: 16564688
   PubMed Web of Science ®Google Scholar
• Bakshi R, Ariyaratana S, Benedict RH, Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001; 58:742 - 8; http://dx.doi.org/10.1001/archneur.58.5.742; PMID: 11346369
   PubMed Web of Science ®Google Scholar
• Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, et al. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler 2011; 17:1202 - 10; http://dx.doi.org/10.1177/1352458511406575; PMID: 21561955
   PubMed Web of Science ®Google Scholar
• Geurts JJG, Pouwels PJW, Uitdehaag BMJ, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236:254 - 60; http://dx.doi.org/10.1148/radiol.2361040450; PMID: 15987979
   PubMed Web of Science ®Google Scholar
• Seewann A, Kooi E-J, Roosendaal SD, Pouwels PJW, Wattjes MP, van der Valk P, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78:302 - 8; http://dx.doi.org/10.1212/WNL.0b013e31824528a0; PMID: 22218278
   PubMed Web of Science ®Google Scholar
• Sethi V, Yousry TA, Muhlert N, Ron M, Golay X, Wheeler-Kingshott C, et al. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry 2012; 83:877 - 82; http://dx.doi.org/10.1136/jnnp-2012-303023; PMID: 22807559
   PubMed Web of Science ®Google Scholar
• Nelson F, Poonawalla A, Hou P, Wolinsky JS, Narayana PA. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler 2008; 14:1214 - 9; http://dx.doi.org/10.1177/1352458508094644; PMID: 18952832
   PubMed Web of Science ®Google Scholar
• Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen-Adad J, Mainero C. Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magn Reson Imaging 2012; 35:537 - 42; http://dx.doi.org/10.1002/jmri.22847; PMID: 22045554
   PubMed Web of Science ®Google Scholar
• de Graaf WL, Kilsdonk ID, Lopez-Soriano A, Zwanenburg JJM, Visser F, Polman CH, et al. Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. Eur Radiol 2012; PMID: 22898935
   PubMed Web of Science ®Google Scholar
• Audoin B, Zaaraoui W, Reuter F, Rico A, Malikova I, Confort-Gouny S, et al. Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis. J Neurol Neurosurg Psychiatry 2010; 81:690 - 5; http://dx.doi.org/10.1136/jnnp.2009.188748; PMID: 20392976
   PubMed Web of Science ®Google Scholar
• Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012; 259:139 - 46; http://dx.doi.org/10.1007/s00415-011-6147-1; PMID: 21720932
   PubMed Web of Science ®Google Scholar
• Calabrese M, Rinaldi F, Mattisi I, Bernardi V, Favaretto A, Perini P, et al. The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology 2011; 77:257 - 63; http://dx.doi.org/10.1212/WNL.0b013e318220abd4; PMID: 21613600
   PubMed Web of Science ®Google Scholar
• Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler 2011; 17:1098 - 106; http://dx.doi.org/10.1177/1352458511404916; PMID: 21586487
   PubMed Web of Science ®Google Scholar
• Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007; 64:1416 - 22; http://dx.doi.org/10.1001/archneur.64.10.1416; PMID: 17923625
   PubMed Web of Science ®Google Scholar
• Calabrese M, Filippi M, Rovaris M, Bernardi V, Atzori M, Mattisi I, et al. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 2009; 15:36 - 41; http://dx.doi.org/10.1177/1352458508096686; PMID: 18755823
   PubMed Web of Science ®Google Scholar
• Calabrese M, Gallo P. Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 2009; 15:933 - 41; http://dx.doi.org/10.1177/1352458509106510; PMID: 19667021
   PubMed Web of Science ®Google Scholar
• Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, et al. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 2010; 67:376 - 83; PMID: 20373349
   PubMed Web of Science ®Google Scholar
• Cohen-Adad J, Benner T, Greve D, Kinkel RP, Radding A, Fischl B, et al. In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis. Neuroimage 2011; 57:55 - 62; http://dx.doi.org/10.1016/j.neuroimage.2011.04.009; PMID: 21511042
   PubMed Web of Science ®Google Scholar
• Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66:1144 - 50; http://dx.doi.org/10.1001/archneurol.2009.174; PMID: 19752305
   PubMed Web of Science ®Google Scholar
• Roosendaal SD, Moraal B, Pouwels PJ, Vrenken H, Castelijns JA, Barkhof F, et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009; 15:708 - 14; http://dx.doi.org/10.1177/1352458509102907; PMID: 19435749
   PubMed Web of Science ®Google Scholar
• Roosendaal SD, Moraal B, Vrenken H, Castelijns JA, Pouwels PJW, Barkhof F, et al. In vivo MR imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging 2008; 27:726 - 31; http://dx.doi.org/10.1002/jmri.21294; PMID: 18302199
   PubMed Web of Science ®Google Scholar
• Geurts JJG, Bö L, Pouwels PJW, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005; 26:572 - 7; PMID: 15760868
   PubMed Web of Science ®Google Scholar
• Nakamura K, Fisher E. Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients. Neuroimage 2009; 44:769 - 76; http://dx.doi.org/10.1016/j.neuroimage.2008.09.059; PMID: 19007895
   PubMed Web of Science ®Google Scholar
• Fisher E, Lee J-C, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008; 64:255 - 65; http://dx.doi.org/10.1002/ana.21436; PMID: 18661561
   PubMed Web of Science ®Google Scholar
• Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64:247 - 54; http://dx.doi.org/10.1002/ana.21423; PMID: 18570297
   PubMed Web of Science ®Google Scholar
• Brink BP, Veerhuis R, Breij ECW, van der Valk P, Dijkstra CD, Bö L. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005; 64:147 - 55; PMID: 15751229
   PubMed Web of Science ®Google Scholar
• van Horssen J, Brink BP, de Vries HE, van der Valk P, Bø L. The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007; 66:321 - 8; http://dx.doi.org/10.1097/nen.0b013e318040b2de; PMID: 17413323
   PubMed Web of Science ®Google Scholar
• Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011; 365:2188 - 97; http://dx.doi.org/10.1056/NEJMoa1100648; PMID: 22150037
   PubMed Web of Science ®Google Scholar
• Kooi EJ, Strijbis EM, van der Valk P, Geurts JJ. Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications. Neurology 2012; 79:1369 - 76; http://dx.doi.org/10.1212/WNL.0b013e31826c1b1c; PMID: 22972651
   PubMed Web of Science ®Google Scholar
• Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, et al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 2012; 79:523 - 30; http://dx.doi.org/10.1212/WNL.0b013e3182635645; PMID: 22764258
   PubMed Web of Science ®Google Scholar
• Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308:1314 - 8; http://dx.doi.org/10.1126/science.1110647; PMID: 15831717
   PubMed Web of Science ®Google Scholar
• Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005; 8:752 - 8; http://dx.doi.org/10.1038/nn1472; PMID: 15895084
   PubMed Web of Science ®Google Scholar
• Melton LM, Keith AB, Davis S, Oakley AE, Edwardson JA, Morris CM. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA. Glia 2003; 44:1 - 12; http://dx.doi.org/10.1002/glia.10276; PMID: 12951652
   PubMed Web of Science ®Google Scholar
• Nakanishi H. Microglial functions and proteases. Mol Neurobiol 2003; 27:163 - 76; http://dx.doi.org/10.1385/MN:27:2:163; PMID: 12777686
   PubMed Web of Science ®Google Scholar
• Taylor DL, Jones F, Kubota ESFCS, Pocock JM. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 2005; 25:2952 - 64; http://dx.doi.org/10.1523/JNEUROSCI.4456-04.2005; PMID: 15772355
   PubMed Web of Science ®Google Scholar
• Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343:938 - 52; http://dx.doi.org/10.1056/NEJM200009283431307; PMID: 11006371
   PubMed Web of Science ®Google Scholar
• Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130:1089 - 104; http://dx.doi.org/10.1093/brain/awm038; PMID: 17438020
   PubMed Web of Science ®Google Scholar
• Torkildsen Ø, Stansberg C, Angelskår SM, Kooi E-J, Geurts JJG, van der Valk P, et al. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol 2010; 20:720 - 9; http://dx.doi.org/10.1111/j.1750-3639.2009.00343.x; PMID: 19919606
   PubMed Web of Science ®Google Scholar
• Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009; 132:3318 - 28; http://dx.doi.org/10.1093/brain/awp200; PMID: 19638446
   PubMed Web of Science ®Google Scholar
• Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68:477 - 93; http://dx.doi.org/10.1002/ana.22230; PMID: 20976767
   PubMed Web of Science ®Google Scholar
• Kooi E-J, Geurts JJG, van Horssen J, Bø L, van der Valk P. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. J Neuropathol Exp Neurol 2009; 68:1021 - 8; http://dx.doi.org/10.1097/NEN.0b013e3181b4bf8f; PMID: 19680141
   PubMed Web of Science ®Google Scholar
• Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci U S A 2004; 101:8168 - 73; http://dx.doi.org/10.1073/pnas.0402765101; PMID: 15148385
   PubMed Web of Science ®Google Scholar
• Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006; 59:478 - 89; http://dx.doi.org/10.1002/ana.20736; PMID: 16392116
   PubMed Web of Science ®Google Scholar
• Lu F, Selak M, O’Connor J, Croul S, Lorenzana C, Butunoi C, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000; 177:95 - 103; http://dx.doi.org/10.1016/S0022-510X(00)00343-9; PMID: 10980305
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443:787 - 95; http://dx.doi.org/10.1038/nature05292; PMID: 17051205
   PubMed Web of Science ®Google Scholar
• Stys PK. Axonal degeneration in multiple sclerosis: is it time for neuroprotective strategies?. Ann Neurol 2004; 55:601 - 3; http://dx.doi.org/10.1002/ana.20082; PMID: 15122698
   PubMed Web of Science ®Google Scholar
• Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009; 8:280 - 91; http://dx.doi.org/10.1016/S1474-4422(09)70043-2; PMID: 19233038
   PubMed Web of Science ®Google Scholar
• Geurts JJG, Wolswijk G, Bö L, van der Valk P, Polman CH, Troost D, et al. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 2003; 126:1755 - 66; http://dx.doi.org/10.1093/brain/awg179; PMID: 12805104
   PubMed Web of Science ®Google Scholar
• Geurts JJG, Wolswijk G, Bö L, Redeker S, Ramkema M, Troost D, et al. Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions. J Neuroimmunol 2005; 158:182 - 90; http://dx.doi.org/10.1016/j.jneuroim.2004.08.012; PMID: 15589052
   PubMed Web of Science ®Google Scholar
• Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, et al. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 2008; 18:52 - 61; http://dx.doi.org/10.1111/j.1750-3639.2007.00101.x; PMID: 17924980
   PubMed Web of Science ®Google Scholar
• Schmierer K, Parkes HG, So P-W, An SF, Brandner S, Ordidge RJ, et al. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 2010; 133:858 - 67; http://dx.doi.org/10.1093/brain/awp335; PMID: 20123726
   PubMed Web of Science ®Google Scholar